Put Options

22 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $4.71 Million - $6.15 Million
118,800 New
118,800 $6.15 Million
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $1.86 Million - $2.11 Million
38,800 New
38,800 $2.1 Million
Q2 2023

Aug 03, 2023

BUY
$63.71 - $70.74 $20.5 Million - $22.7 Million
321,000 Added 208.98%
474,600 $30.4 Million
Q1 2023

May 04, 2023

SELL
$65.71 - $74.53 $22 Million - $25 Million
-335,000 Reduced 68.56%
153,600 $10.6 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $33.5 Million - $39.6 Million
488,600 New
488,600 $35.2 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $7.33 Million - $8.54 Million
136,600 Added 128.5%
242,900 $15.1 Million
Q3 2021

Nov 09, 2021

BUY
$59.17 - $69.31 $5.92 Million - $6.93 Million
100,000 Added 1587.3%
106,300 $6.29 Million
Q1 2021

May 13, 2021

SELL
$59.34 - $66.74 $24.7 Million - $27.8 Million
-417,000 Reduced 98.51%
6,300 $398,000
Q4 2020

Feb 11, 2021

BUY
$57.74 - $65.43 $8.79 Million - $9.96 Million
152,300 Added 56.2%
423,300 $26.3 Million
Q3 2020

Nov 12, 2020

SELL
$57.43 - $63.64 $58.6 Million - $65 Million
-1,021,000 Reduced 79.02%
271,000 $16.3 Million
Q2 2020

Aug 12, 2020

BUY
$54.82 - $64.09 $39.1 Million - $45.7 Million
712,900 Added 123.1%
1,292,000 $76 Million
Q1 2020

May 13, 2020

SELL
$46.4 - $67.43 $1.14 Billion - $1.66 Billion
-24,559,800 Reduced 97.7%
579,100 $32.3 Million
Q4 2019

Feb 10, 2020

BUY
$49.21 - $64.19 $1.2 Billion - $1.57 Billion
24,443,900 Added 3517.11%
25,138,900 $1.61 Billion
Q3 2019

Nov 14, 2019

SELL
$42.77 - $50.71 $18 Million - $21.4 Million
-421,300 Reduced 37.74%
695,000 $35.2 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $45.9 Million - $50.8 Million
-1,029,300 Reduced 47.97%
1,116,300 $50.6 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $74.2 Million - $88.5 Million
1,644,400 Added 328.09%
2,145,600 $102 Million
Q4 2018

Feb 14, 2019

SELL
$48.76 - $63.23 $112,148 - $145,429
-2,300 Reduced 0.46%
501,200 $26.1 Million
Q3 2018

Nov 14, 2018

SELL
$55.19 - $62.25 $14.7 Million - $16.6 Million
-267,100 Reduced 34.66%
503,500 $31.3 Million
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $37.1 Million - $46.2 Million
-733,400 Reduced 48.76%
770,600 $42.6 Million
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $54.4 Million - $62.6 Million
908,000 Added 152.35%
1,504,000 $95.1 Million
Q4 2017

Feb 14, 2018

SELL
$59.94 - $65.35 $617,382 - $673,104
-10,300 Reduced 1.7%
596,000 $36.5 Million
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $33.5 Million - $38.6 Million
606,300
606,300 $38.6 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.